In a landmark May 2025 study from the Korea Institute of Science and Technology, researchers uncovered that cannabidiol (CBD) can significantly enhance the cancer-fighting power of etoposide in non-small cell lung cancer (NSCLC). By activating p53-driven autophagic cell death and suppressing key cancer pathways—independent of traditional cannabinoid receptors—CBD emerges as a potent therapeutic ally in the fight against lung cancer. Continue reading CBD Scores a Knockout Combo: New Research Reveals Cannabis Compound Boosts Cancer Drug Performance Without Playing by the Old Rules